^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    YE-NEO 001

    i
    Associations
    News

    Trials

    Company:
    ImmunityBio
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. (NCT03552718)
    Phase 1
    NantBioScience, Inc.
    Active, not recruiting
    Last update posted :
    06/26/2023
    Initiation :
    08/10/2018
    Primary completion :
    07/15/2025
    Completion :
    12/30/2025
    HER-2
    |
    HER-2 positive • HR positive • HR positive + HER-2 positive
    |
    YE-NEO 001